Literature DB >> 11122994

Mania in neurologic disorders.

M F Mendez1.   

Abstract

Neurologic disorders can produce "secondary" mania. Clinicians must distinguish secondary mania from primary, idiopathic manic-depressive illness (MBI). In addition to medical and drug-induced causes of secondary mania, neurologic causes usually develop in older patients who may lack a strong family history of MDI. Neurologic causes of mania include focal strokes in the right basotemporal or inferofrontal region, strokes or tumors in the perihypothalamic region, Huntington's disease and other movement disorders, multiple sclerosis and other white matter diseases, head trauma, infections such as neurosyphilis and Creutzfeldt-Jakob disease, and frontotemporal dementia. Patients with new-onset mania require an evaluation that includes a thorough history, a neurologic examination, neuroimaging, and other selected tests. The management of patients with neurologic mania involving correcting the underlying disorder when possible and the judicious use of drugs such as the anticonvulsant medications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122994     DOI: 10.1007/s11920-000-0030-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  76 in total

1.  Creutzfeldt-Jakob disease presenting as secondary mania.

Authors:  I Lendvai; S M Saravay; M D Steinberg
Journal:  Psychosomatics       Date:  1999 Nov-Dec       Impact factor: 2.386

2.  Brain injury-induced rapid-cycling affective disorder successfully treated with valproate.

Authors:  A Monji; I Yoshida; H Koga; K Tashiro; N Tashiro
Journal:  Psychosomatics       Date:  1999 Sep-Oct       Impact factor: 2.386

3.  Cerebral infarct presenting as mania.

Authors:  R G Fawcett
Journal:  J Clin Psychiatry       Date:  1991-08       Impact factor: 4.384

4.  [Familial metachromatic leukodystrophy as a cause of psychotic manifestations in young adults].

Authors:  M Wender; D Pruchnik-Wolińska; W Paprzycki; B Czartoryska
Journal:  Psychiatr Pol       Date:  1998 Jan-Feb       Impact factor: 1.657

5.  Psychoses following war brain injuries.

Authors:  K A Achté; E Hillbom; V Aalberg
Journal:  Acta Psychiatr Scand       Date:  1969       Impact factor: 6.392

6.  Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene.

Authors:  J L Laplanche; K H Hachimi; I Durieux; P Thuillet; L Defebvre; N Delasnerie-Lauprêtre; K Peoc'h; J F Foncin; A Destée
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

7.  Manic episodes in two patients treated with interferon alpha.

Authors:  D Strite; A D Valentine; C A Meyers
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1997       Impact factor: 2.198

8.  Comparison of mania and depression after brain injury: causal factors.

Authors:  R G Robinson; J D Boston; S E Starkstein; T R Price
Journal:  Am J Psychiatry       Date:  1988-02       Impact factor: 18.112

9.  Mood Disorders in Neurodegenerative Diseases.

Authors: 
Journal:  Semin Clin Neuropsychiatry       Date:  1996-10

10.  Mania after brain injury: neuroradiological and metabolic findings.

Authors:  S E Starkstein; H S Mayberg; M L Berthier; P Fedoroff; T R Price; R F Dannals; H N Wagner; R Leiguarda; R G Robinson
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

View more
  13 in total

1.  Disadvantageous decision-making on a rodent gambling task is associated with increased motor impulsivity in a population of male rats.

Authors:  Michael M Barrus; Jay G Hosking; Fiona D Zeeb; Melanie Tremblay; Catharine A Winstanley
Journal:  J Psychiatry Neurosci       Date:  2015-03       Impact factor: 6.186

2.  Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders?

Authors:  Gianluca Floris; Giuseppe Borghero; Antonino Cannas; Francesca Di Stefano; Maria R Murru; Daniela Corongiu; Stefania Cuccu; Stefania Tranquilli; Maria G Marrosu; Adriano Chiò; Francesco Marrosu
Journal:  J Neurol       Date:  2013-01-13       Impact factor: 4.849

3.  The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease.

Authors:  Josh D Woolley; Baber K Khan; Nikhil K Murthy; Bruce L Miller; Katherine P Rankin
Journal:  J Clin Psychiatry       Date:  2011-02       Impact factor: 4.384

Review 4.  Update on the Epidemiology, Diagnosis, and Treatment of Mania in Older-Age Bipolar Disorder.

Authors:  Peijun Chen; Annemiek Dols; Soham Rej; Martha Sajatovic
Journal:  Curr Psychiatry Rep       Date:  2017-08       Impact factor: 5.285

Review 5.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

Review 6.  Mania in the medically ill.

Authors:  Monica Arora; Joan Daughton
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

Review 7.  Bipolar Disorder Among Patients Diagnosed With Frontotemporal Dementia.

Authors:  Mario F Mendez; Leila Parand; Golnoush Akhlaghipour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2020-06-05       Impact factor: 2.198

8.  Syndrome-Based Prescription to Optimize Psychotropics: Are CHROME Criteria a Game Changer?

Authors:  Ruben Muñiz; Jorge López-Alvarez; Luis Agüera-Ortiz; Luis Perea; Javier Olazarán
Journal:  Front Psychiatry       Date:  2021-04-22       Impact factor: 4.157

9.  Huntington's Disease and Striatal Signaling.

Authors:  Emmanuel Roze; Emma Cahill; Elodie Martin; Cecilia Bonnet; Peter Vanhoutte; Sandrine Betuing; Jocelyne Caboche
Journal:  Front Neuroanat       Date:  2011-08-23       Impact factor: 3.856

10.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.